Your browser doesn't support javascript.
loading
The activated conformation of integrin ß7 is a novel multiple myeloma-specific target for CAR T cell therapy.
Hosen, Naoki; Matsunaga, Yukiko; Hasegawa, Kana; Matsuno, Hiroshi; Nakamura, Yuki; Makita, Mio; Watanabe, Kouki; Yoshida, Mikako; Satoh, Kei; Morimoto, Soyoko; Fujiki, Fumihiro; Nakajima, Hiroko; Nakata, Jun; Nishida, Sumiyuki; Tsuboi, Akihiro; Oka, Yoshihiro; Manabe, Masahiro; Ichihara, Hiroyoshi; Aoyama, Yasutaka; Mugitani, Atsuko; Nakao, Takafumi; Hino, Masayuki; Uchibori, Ryosuke; Ozawa, Keiya; Baba, Yoshihiro; Terakura, Seitaro; Wada, Naoki; Morii, Eiichi; Nishimura, Junichi; Takeda, Kiyoshi; Oji, Yusuke; Sugiyama, Haruo; Takagi, Junichi; Kumanogoh, Atsushi.
Afiliação
  • Hosen N; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Matsunaga Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Hasegawa K; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Matsuno H; Laboratory of Protein Synthesis and Expression, Institute for Protein Research, Osaka University, Osaka, Japan.
  • Nakamura Y; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Makita M; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Watanabe K; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Yoshida M; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Satoh K; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Morimoto S; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Fujiki F; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nakajima H; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nakata J; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nishida S; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tsuboi A; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Oka Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Manabe M; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Ichihara H; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Aoyama Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Mugitani A; WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Nakao T; Department of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan.
  • Hino M; Department of Hematology, Fuchu Hospital, Osaka, Japan.
  • Uchibori R; Department of Hematology, Fuchu Hospital, Osaka, Japan.
  • Ozawa K; Department of Hematology, Fuchu Hospital, Osaka, Japan.
  • Baba Y; Department of Hematology, Osaka City General Hospital, Osaka, Japan.
  • Terakura S; Department of Hematology and Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Wada N; Division of Immuno-Gene & Cell Therapy (Takara Bio), Jichi Medical University, Tochigi, Japan.
  • Morii E; Division of Immuno-Gene & Cell Therapy (Takara Bio), Jichi Medical University, Tochigi, Japan.
  • Nishimura J; Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Takeda K; Division of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
  • Oji Y; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Sugiyama H; Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Takagi J; Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kumanogoh A; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Nat Med ; 23(12): 1436-1443, 2017 Dec.
Article em En | MEDLINE | ID: mdl-29106400
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Cadeias beta de Integrinas / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Nat Med Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Cadeias beta de Integrinas / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Nat Med Ano de publicação: 2017 Tipo de documento: Article